Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc L. Cohen, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Cohen M, Diez JE, Levine GN, Ferguson JJ, Morrow DA, Rao SV, Zidar JP. Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. J Invasive Cardiol. 2007 Dec; 19(12):525-38; quiz 539-40. PMID: 18180524.
    Citations: 5     Fields:    Translation:Humans
  2. Murphy SA, Gibson CM, Morrow DA, Van de Werf F, Menown IB, Goodman SG, Mahaffey KW, Cohen M, McCabe CH, Antman EM, Braunwald E. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J. 2007 Sep; 28(17):2077-86. PMID: 17600038.
    Citations: 23     Fields:    Translation:HumansPHPublic Health
  3. Gibson CM, Murphy SA, Montalescot G, Morrow DA, Ardissino D, Cohen M, Gulba DC, Kracoff OH, Lewis BS, Roguin N, Antman EM, Braunwald E. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. J Am Coll Cardiol. 2007 Jun 12; 49(23):2238-46. PMID: 17560287.
    Citations: 18     Fields:    Translation:Humans
  4. Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, de Lemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA. 2004 Jul 07; 292(1):89-96. PMID: 15238596.
    Citations: 28     Fields:    Translation:Humans
  5. Ferguson JJ, Antman EM, Bates ER, Cohen M, Every NR, Harrington RA, Pepine CJ, Theroux P. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Am Heart J. 2003 Oct; 146(4):628-34. PMID: 14564315.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  6. Spinler SA, Inverso SM, Cohen M, Goodman SG, Stringer KA, Antman EM. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies. Am Heart J. 2003 Jul; 146(1):33-41. PMID: 12851605.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  7. Cohen M, Antman EM. Enoxaparin and unfractionated heparin in acute coronary syndromes without ST-segment elevation. Thromb Haemost. 2002 Nov; 88(5):884-6; 886-7. PMID: 12428118.
    Citations:    Fields:    Translation:Humans
  8. Cohen M. Defining optimal therapy for the thrombolysis-ineligible patient. Clin Cardiol. 2002 Nov; 25(11 Suppl 1):I23-6. PMID: 12428816.
    Citations:    Fields:    Translation:Humans
  9. Cohen M, Fasseas P, Singh VP, McBride R, Orford JL, Kussmaul WG. Impact of intra-aortic balloon counterpulsation with different balloon volumes on cardiac performance in humans. Catheter Cardiovasc Interv. 2002 Oct; 57(2):199-204. PMID: 12357520.
    Citations: 1     Fields:    Translation:HumansCTClinical Trials
  10. Kereiakes DJ, Montalescot G, Antman EM, Cohen M, Darius H, Ferguson JJ, Grines C, Karsch KR, Kleiman NS, Moliterno DJ, Steg PG, Teirstein P, Van de Werf F, Wallentin L. Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensus. Am Heart J. 2002 Oct; 144(4):615-24. PMID: 12360156.
    Citations: 4     Fields:    Translation:Humans
  11. Cohen M, Théroux P, Borzak S, Frey MJ, White HD, Van Mieghem W, Senatore F, Lis J, Mukherjee R, Harris K, Bigonzi F. Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin. Am Heart J. 2002 Sep; 144(3):470-7. PMID: 12228784.
    Citations: 17     Fields:    Translation:HumansCTClinical Trials
  12. Fox KA, Antman EM, Cohen M, Bigonzi F. Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. Am J Cardiol. 2002 Sep 01; 90(5):477-82. PMID: 12208405.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  13. Levy JH, Goodnough LT, Greilich PE, Parr GV, Stewart RW, Gratz I, Wahr J, Williams J, Comunale ME, Doblar D, Silvay G, Cohen M, Jahr JS, Vlahakes GJ. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg. 2002 Jul; 124(1):35-42. PMID: 12091806.
    Citations: 19     Fields:    Translation:HumansAnimalsCTClinical Trials
  14. Cohen M, Ferguson JJ, Freedman RJ, Miller MF, Reddy RC, Ohman EM, Stone GW, Christenson J, Joseph DL. Comparison of outcomes after 8 vs. 9.5 French size intra-aortic balloon counterpulsation catheters based on 9,332 patients in the prospective Benchmark registry. Catheter Cardiovasc Interv. 2002 Jun; 56(2):200-6. PMID: 12112913.
    Citations:    Fields:    Translation:Humans
  15. Sabatine MS, McCabe CH, Morrow DA, Giugliano RP, de Lemos JA, Cohen M, Antman EM, Braunwald E. Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am Heart J. 2002 Jun; 143(6):966-70. PMID: 12075250.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  16. Cohen M, Antman EM. Superiority of enoxaparin over unfractionated heparin for the treatment of acute coronary syndromes. Pharmacotherapy. 2002 Apr; 22(4):542-6; author reply 546-50. PMID: 11939692.
    Citations:    Fields:    Translation:Humans
  17. Cohen M. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update. Drugs. 2002; 62(12):1755-70. PMID: 12149045.
    Citations: 1     Fields:    Translation:Humans
  18. Cohen M, Antman EM, Murphy SA, Radley D. Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. Am Heart J. 2002 Jan; 143(1):63-9. PMID: 11773913.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Cohen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (85)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.